MFG
GSK icon

Mendota Financial Group’s GSK GSK Stock Holding History

Mendota Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26
Closed -$880 – 198
2024
Q4 		$880 Sell
26
-9
-26% -$324 ﹤0.01% 311
2024
Q3 		$1.43K Buy
35
+13
+59% +$532 ﹤0.01% 327
2024
Q2 		$847 Buy
+22
New +$925 ﹤0.01% 307

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mendota Financial Group's GSK Position: Q1 2025 in Review

Mendota Financial Group sold out of GSK (GSK) in Q1 2025, closing a stake of 26 shares — an estimated $880 sold.

Mendota Financial Group first reported a position in GSK in Q2 2024 and held it in 3 quarters. The position peaked at $1.43K in Q3 2024. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Mendota Financial Group reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
  • Mendota Financial Group sold 26 GSK shares in Q1 2025, an estimated $880.
  • Mendota Financial Group first reported a position in GSK in Q2 2024 and held it in 3 quarters.
  • Mendota Financial Group's GSK position peaked at $1.43K in Q3 2024.
  • 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Mendota Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.